Suchergebnisse - "Gangat, Naseema"

PubPharm (461)

1

Incidental discovery of KIT-mutated mastocytoma in a colon polyp

enthalten in: American journal of hematology | 2024

von Gangat, N. | McPhail, E. | Reichard, K. | +3

2

Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents

enthalten in: British journal of haematology | 2024

von Johnson, I. | Karrar, O. | Rana, M. | +15

3

New drugs in myelofibrosis : Critical assessment of additional value to monotherapy with JAK inhibitors

enthalten in: American journal of hematology | 2024

von Gangat, N. | Tefferi, A.

4

Methodological challenges in the development of endpoints for myelofibrosis clinical trials

enthalten in: The Lancet. Haematology | 2024

von Barosi, G. | Tefferi, A. | Gangat, N. | +8

5

Emergence of TP53 mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine

enthalten in: Haematologica | 2024

von Gangat, N. | Bellam, N. | Reichard, K. | +1

6

TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)

enthalten in: British journal of haematology | 2024

von Tefferi, A. | Fleti, F. | Chan, O. | +18

7

CALR mutation burden in essential thrombocythemia and disease outcome

enthalten in: Blood | 2024

von Guglielmelli, P. | Szuber, N. | Gangat, N. | +15

8

Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent

enthalten in: Haematologica | 2024

von Steinauer, N. | McCullough, K. | Al-Kali, A. | +16

9

Venetoclax in the treatment of acute myeloid leukemia : Beyond VIALE-A

enthalten in: American journal of hematology | 2024

von Gangat, N. | Tefferi, A.

10

Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant

enthalten in: Blood cancer journal | 2024

von Tefferi, A. | Pardanani, A. | Begna, K. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[47]